TTP Cambridge Half Marathon 2027

TTP Cambridge Half Marathon 2027 TTP Cambridge Half Marathon 2027 TTP Cambridge Half Marathon 2027
  1. What:

    A spectacular route through this historic city awaits you at the Cambridge Half Marathon. This event sells out in hours so don’t miss your chance to join team Brain Tumour Research .Please note, the fundraising target is £274.

  2. When:

    Mar 14 2027 at 09:30

  3. Where:

    Midsummer Common, Victoria Avenue, Cambridge

  • £30.00 GBP

About

A 13.1-mile route takes you on a one-lap tour of this beautiful historic city. Starting and finishing on Midsummer Common, you’ll be inspired by Cambridge’s famous landmarks, college courtyards and stunning countryside on your run for research. The incredible crowd support will carry you every mile and, with the promise of a flat and fast course, you could be on track for a PB whether it’s your first half marathon or you’re a more experienced runner. Join our team and raise vital funds for Brain Tumour Research, and feel extra proud as you cross the finish line, knowing your efforts will help us get closer to a cure for brain tumours.

 Please note, the fundraising target is £274.

Location and Timings

Location
Midsummer Common, Victoria Avenue, Cambridge
Start time
Sun, 14 March 27, 09:30AM

Logistics

Registration Fee: £30

Minimum Sponsorship: £274

Distance: 13.1 miles

Community support contact:

Charlie Allsebrook

fundraising@braintumourresearch.org

How we'll support you

Joining this event as a runner for Brain Tumour Research you will receive:

  • A Fundraising Pack
  • A branded t-shirt
  • Dedicated fundraising help and support, including any assistance needed in setting up your online fundraising page
  • Access to a Facebook Group for sharing updates, useful tips on how to maximise your fundraising, and smashing your targets!
  • PR support where applicable and the opportunity to share story with us (if you want to)
  • A Brain Tumour Research Medal

Help us find a cure

Already secured a place?

Join the Brain Tumour Research Team.